Natco Pharma gets CDSCO nod to manufacture, market anti neoplastic drug Idelalisib Dr. Divya Colin16 March 2022 6:52 PM ISTNew Delhi: In a significant development, Natco Pharma has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control...
Novartis gets CDSCO panel go ahead for Asciminib Phase 3 trial Roshni Dhar21 Nov 2021 5:18 PM ISTIn a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs...
Health Bulletin 20/November/2021 Roshni Dhar20 Nov 2021 4:17 PM ISTHere are Top Health stories of the dayDuty of Medical Council to ensure that doctors do not indulge in offences: Madras HCHolding that it is the duty...
Novartis gets CDSCO panel nod to conduct phase 3 study of anti-cancer drug Asciminib Medical Dialogues Team18 Nov 2021 4:25 PM ISTNew Delhi: In a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the...
Nilotinib found safe and effective for Alzheimer's disease in Clinical trial Hina Zahid29 May 2020 6:30 PM ISTWASHINGTON - A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds...
No shortage of essential drugs, other medical products in Kashmir: DFCO Medical Dialogues Bureau4 Sept 2019 9:15 AM ISTThe officials said that major companies operating in the valley are providing regular supplies of almost all categories of drugs including...
